Publisher & Syndication Partner Liability Waiver The publisher, its editors, authors, affiliates, syndication partners, and associated content distributors assume no responsibility or liability for any loss, damage, or injury alleged to be caused-directly or indirectly-by the information presented in this article or by any product discussed
Once-Weekly Convenience with EllievaTec This compounded formula utilizes EllievaTec, a proprietary absorption technology developed over more than a decade and designed to support delivery through the oral cavity
Drinking water throughout the day helps replace lost fluids
Lastly, keep all your routine appointments and lab check-ups
Statistical significance was assessed using analysis of variance (ANOVA) followed by Tukeys multiple comparison tests
Novo said last week that CagriSema was "well-tolerated" and that the most common adverse effects were gastrointestinal, but they were "mild to moderate and diminished over time." "Investors are looking for treatment options that are best in class and will secure Novo's place in the obesity drug market," Soren Lontoft, pharma equity analyst at Sydbank, told CNBC over the phone Tuesday
.png)
